Literature DB >> 29535161

IGF1 receptor signaling pathways.

Fumihiko Hakuno1, Shin-Ichiro Takahashi1.   

Abstract

Insulin-like growth factors (IGFs) bind specifically to the IGF1 receptor on the cell surface of targeted tissues. Ligand binding to the α subunit of the receptor leads to a conformational change in the β subunit, resulting in the activation of receptor tyrosine kinase activity. Activated receptor phosphorylates several substrates, including insulin receptor substrates (IRSs) and Src homology collagen (SHC). Phosphotyrosine residues in these substrates are recognized by certain Src homology 2 (SH2) domain-containing signaling molecules. These include, for example, an 85 kDa regulatory subunit (p85) of phosphatidylinositol 3-kinase (PI 3-kinase), growth factor receptor-bound 2 (GRB2) and SH2-containing protein tyrosine phosphatase 2 (SHP2/Syp). These bindings lead to the activation of downstream signaling pathways, PI 3-kinase pathway and Ras-mitogen-activated protein kinase (MAP kinase) pathway. Activation of these signaling pathways is known to be required for the induction of various bioactivities of IGFs, including cell proliferation, cell differentiation and cell survival. In this review, the well-established IGF1 receptor signaling pathways required for the induction of various bioactivities of IGFs are introduced. In addition, we will discuss how IGF signals are modulated by the other extracellular stimuli or by themselves based on our studies.
© 2018 Society for Endocrinology.

Entities:  

Keywords:  MAP kinase; PI 3-kinase; insulin receptor substrate (IRS); insulin-like growth factor (IGF); insulin-like growth factor (IGF)-I receptor; signal transduction

Mesh:

Substances:

Year:  2018        PMID: 29535161     DOI: 10.1530/JME-17-0311

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  89 in total

1.  Lung megakaryocytes display distinct transcriptional and phenotypic properties.

Authors:  Anthony K Yeung; Carlos Villacorta-Martin; Stephanie Hon; Jason R Rock; George J Murphy
Journal:  Blood Adv       Date:  2020-12-22

2.  Session 2SHP report-decoding intracellular architecture using visualizing device development and mathematical modeling.

Authors:  Akira Kitamura; Kazuya Kabayama
Journal:  Biophys Rev       Date:  2020-02-15

Review 3.  Hyperinsulinaemia in cancer.

Authors:  Emily J Gallagher; Derek LeRoith
Journal:  Nat Rev Cancer       Date:  2020-09-09       Impact factor: 60.716

4.  World leaders describe the latest in IGF research.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  J Mol Endocrinol       Date:  2018-07       Impact factor: 5.098

5.  Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia.

Authors:  Leonardo Luís Artico; Angelo Brunelli Albertoni Laranjeira; Livia Weijenborg Campos; Juliana Ronchi Corrêa; Priscila Pini Zenatti; José Barreto Campello Carvalheira; Sandra Regina Brambilla; Alexandre Eduardo Nowill; Silvia Regina Brandalise; José Andrés Yunes
Journal:  Blood Adv       Date:  2021-09-28

6.  IGF1- and BM-MSC-incorporating collagen-chitosan scaffolds promote wound healing and hair follicle regeneration.

Authors:  Ying Xia; Jianshe Chen; Juan Ding; Jianqing Zhang; Hong Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

7.  Insulin-like growth factor 1-receptor signaling stimulates GRP78 expression through the PI3K/AKT/mTOR/ATF4 axis.

Authors:  Dat P Ha; Amy S Lee
Journal:  Cell Signal       Date:  2020-08-14       Impact factor: 4.315

8.  IGF-1 infusion to fetal sheep increases organ growth but not by stimulating nutrient transfer to the fetus.

Authors:  Jane Stremming; Sara Heard; Alicia White; Eileen I Chang; Steven C Shaw; Stephanie R Wesolowski; Sonnet S Jonker; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-01-11       Impact factor: 4.310

9.  Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood.

Authors:  Masanobu Fujimoto; Jane C Khoury; Philip R Khoury; Bhanu Kalra; Ajay Kumar; Patrick Sluss; Claus Oxvig; Vivian Hwa; Andrew Dauber
Journal:  Eur J Endocrinol       Date:  2020-03       Impact factor: 6.664

10.  Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank.

Authors:  Frank Qian; Dezheng Huo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.